CD147 promotes cell motility via upregulation of p190-B RhoGAP in hepatocellular carcinoma
Ruo Chen(Beijing University of Chinese Medicine), Hong‐Yong Cui(National Medical Products Administration)
Cited by 7
Related Papers
Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial
|Signal Transduction and Targeted Therapy|2021|66
CD147 deficiency in T cells prevents thymic involution by inhibiting the EMT process in TECs in the presence of TGFβ
|Cellular and Molecular Immunology|2020|29